Our Stories
At BeOne we are creating a future without cancer. These are the stories that bring our vision to life.
One Save Changes Everything — And We’re Built To Be Ready
Progress in cancer is cumulative, collective, and built save by save. See how BeOne brings together innovation, an accelerated pipeline, and access to make more saves possible.
Blood Cancer Awareness
Blood cancer care is evolving rapidly, creating new possibilities for patients and clinicians. BeOne is helping turn those possibilities into progress by advancing innovation, supporting more informed care decisions and expanding access so more patients can benefit from scientific advances. Learn more below.
Every person living with CLL is different and treatment decisions should reflect their individual needs. As part of our broader efforts to support more informed, personalized care, hear from a clinician about why there is no one-size-fits-all approach to CLL treatment.
Advances in blood cancer care can only make a difference when patients can access the right care. As part of our work to better understand and address barriers to treatment, explore new insights into where gaps exist across the CLL patient journey.
Being informed can help patients play a more active role in their care. As part of our commitment to supporting patients throughout their journey, discover resources designed to help people living with CLL better understand and navigate their care.
Blood Cancer Awareness
Blood cancer care is evolving rapidly, creating new possibilities for patients and clinicians. BeOne is helping turn those possibilities into progress by advancing innovation, supporting more informed care decisions and expanding access so more patients can benefit from scientific advances. Learn more below.
AI is Shaping the Future of Blood Cancer Care: Here’s How Patients Can Harness It Safely
Why AI Cancer Care Tools Must Be Developed With Patients and Advocates
Patients Are Asking Chatbots About Their Cancer: Here’s How to Use Them Correctly
Cancer Care
Stories that Inspire Us
No Patient Like Me
Hear from John and Julio about how they navigated their conversations about CLL treatment with their doctors and ensured their voice was heard.
Active monitoring: empowering patients with CLL
When Peter was diagnosed with Chronic Lymphocytic Leukemia (CLL), his world was turned upside down. But by building a strong connection with his healthcare team and learning more about CLL, Peter turned his fears into determination.
Read All Stories
Read the latest stories from BeOne – from the research we’re driving ahead for people with cancer, to the patients who inspire our work, to how we do our best for the communities where we live and work.
- Innovation
- Culture
- Patients
- Impact
- Partnerships
- All Stories
- Innovation
- Culture
- Patients
- Impact
- Partnerships
- All Stories
Blood Cancer Awareness Month: More is Possible
How Advances in CLL Treatment Are Building Momentum
Decades of research have transformed the treatment options for chronic lymphocytic leukemia (CLL) — with even more on the horizon.
Building Skills, Confidence and Connections: Interns Reflect on Their Summer at BeOne
From hands-on projects and professional development to mentorship and meaningful collaboration, BeOne interns share what made this summer a memorable and impactful experience.
Hear from Dr. Lydia Scarfò on Patient-Centered Care in Chronic Lymphocytic Leukemia
BeOne Medicines Q2 FY2026 Financial Results and Business Updates
No Patient Like Me
BeOne Expands U.S. Manufacturing in Hopewell to Advance Innovative Cancer Medicines
BeOne Medicines is expanding its Princeton West Innovation Campus in Hopewell, New Jersey, with a $300 million investment that will add small molecule manufacturing capabilities,…
BTK Inhibitors Explained: How Targeted Therapy Is Changing Blood Cancer
BTK inhibitors have changed treatment for patients with certain leukemias and lymphomas, and researchers are still finding ways to make them better.
Test Slider
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec sed orci eros. Sed eget ante ut massa eleifend rutrum mollis id massa. Ut vitae scelerisque…
How Advances in CLL Treatment Are Building Momentum
Decades of research have transformed the treatment options for chronic lymphocytic leukemia (CLL) — with even more on the horizon.
BeOne Medicines Q2 FY2026 Financial Results and Business Updates
BeOne Expands U.S. Manufacturing in Hopewell to Advance Innovative Cancer Medicines
BeOne Medicines is expanding its Princeton West Innovation Campus in Hopewell, New Jersey, with a $300 million investment that will add small molecule manufacturing capabilities,…
Building a Hematology Program with Staying Power – Insights Leading into EHA 2026
Building a Hematology Program with Staying Power – Insights Leading into EHA 2026
Translating Promise into Progress at ASCO 2026
ASCO 2026’s theme, “The Science and Practice of Translation: Improving Cancer Outcomes Worldwide,” captures a defining challenge in oncology today: how to turn scientific insight…
One Save Changes Everything — And We’re Built To Be Ready
Our new corporate campaign, One Save Changes Everything, is built on a simple observation: that cancer care moves forward in a series of seemingly small,…
BeOne Medicines Q1 2026 Financial Results and Business Updates
The Hidden Burdens of Cancer Care: When Insurers Override Doctors
Five Ways Artificial Intelligence Is Transforming the Patient Blood Cancer Journey
Building Skills, Confidence and Connections: Interns Reflect on Their Summer at BeOne
From hands-on projects and professional development to mentorship and meaningful collaboration, BeOne interns share what made this summer a memorable and impactful experience.
One Save Changes Everything — And We’re Built To Be Ready
Our new corporate campaign, One Save Changes Everything, is built on a simple observation: that cancer care moves forward in a series of seemingly small,…
Cultivating Personal and Professional Growth
Why BeOne?
Our Global Competencies
Pushing Science Forward for Patients
Meet Danny Lu: Putting Patients First
A Culture that Inspires Excellence
Our Patient-First Approach
Blood Cancer Awareness Month: More is Possible
Hear from Dr. Lydia Scarfò on Patient-Centered Care in Chronic Lymphocytic Leukemia
BTK Inhibitors Explained: How Targeted Therapy Is Changing Blood Cancer
BTK inhibitors have changed treatment for patients with certain leukemias and lymphomas, and researchers are still finding ways to make them better.
Strengthening Patient Access in Oncology Through Advocacy
BeOne Medicines has made building strong partnerships with patient organizations a deliberate, long-term practice, one that is integral to the patient-first approach that defines BeOne.
CLL Navigator™: A Digital Community for People Living with CLL
Why AI Cancer Care Tools Must Be Developed With Patients and Advocates
AI is Shaping the Future of Blood Cancer Care: Here’s How Patients Can Harness It Safely
Patients Are Asking Chatbots About Their Cancer: Here’s How to Use Them Correctly
Active monitoring: empowering patients with CLL
One Save Changes Everything — And We’re Built To Be Ready
Our new corporate campaign, One Save Changes Everything, is built on a simple observation: that cancer care moves forward in a series of seemingly small,…
2024 RBS Report Details Progress Across Key Priorities
Light the Night: Raising Cancer Awareness
BeOne’s Commitment to Responsible Business & Sustainability
BeOne Collaboration with The Max Foundation
